Long non-coding RNA FENDRR reduces prostate cancer malignancy by competitively binding miR-18a-5p with RUNX1

Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
Guanying ZhangJianchang Li

Abstract

Prostate cancer (PCa) is one of the most commonly diagnosed malignancy in men in the western world. We aim to investigate the biological role of long non-coding RNA FENDRR and its mechanism in PCa. We determined the expression of FENDRR and miR-18a-5p in PCa tissues and examined the regulatory mechanism in PCa cell lines. FENDRR transcripts in human PCa tissues were significantly decreased compared with the normal controls. Reduced expression of FENDRR was correlated with the increase of pathological degree and poor prognosis in PCa patients. Upregulation of FENDRR inhibited cell proliferation, increased apoptosis and decreased invasion and migration ability, which was inhibited by miR-18a-5p mimic. Knockdown of FENDRR resulted in a significant increase of PCa cell proliferation and decrease of apoptosis and this effect was inhibited miR-18a-5p inhibitor. FENDRR and RUNX1 contain potential target sites for miR-18a-5p. miR-18a-5p mimic inhibited RUNX1 expression and luciferase activity. FENDRR could increase RUNX1 expression, which was inhibited by miR-18a-5p. The effect of FENDRR on cell proliferation, apoptosis and invasion and migration ability was suppressed by silence of RUNX1. These results position FENDRR/miR-18a-5p/RUNX1...Continue Reading

References

Feb 27, 2007·Cell·Bernd SchuettengruberGiacomo Cavalli
Apr 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D Andrew LoblawUNKNOWN American Society of Clinical Oncology
May 19, 2007·Science·Philipp KapranovThomas R Gingeras
Jul 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ahmad M KhalilJohn L Rinn
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Apr 15, 2011·Molecular Cancer·Ewan A GibbWan L Lam
Nov 24, 2012·Nucleic Acids Research·Geng ChenQinghua Cui
Aug 28, 2013·The Journal of Clinical Investigation·Susumu GoyamaJames C Mulloy
Dec 19, 2013·Cancer Metastasis Reviews·Francesco CreaCheryl D Helgason
Apr 24, 2014·Cancer Biology & Therapy·Vanessa Paiva Leite de SousaLuis Felipe Ribeiro Pinto
May 17, 2014·Frontiers in Immunology·Harm WestdorpI Jolanda M de Vries
Jun 27, 2014·Seminars in Cell & Developmental Biology·Je-Hyun YoonMyriam Gorospe
Jul 30, 2014·European Journal of Epidemiology·Ellen T ChangJack S Mandel
Dec 31, 2014·Cancer Biomarkers : Section a of Disease Markers·Cillian ClancyMichael J Kerin
Apr 5, 2016·Nature Reviews. Genetics·Daniel W Thomson, Marcel E Dinger
May 5, 2017·Cell Death & Disease·Chen LiangZhong-Liang Ma
Jul 25, 2017·Biochemical and Biophysical Research Communications·Huazhi Geng, Jun Guan

❮ Previous
Next ❯

Citations

Nov 28, 2019·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Chiara FormicaDorien J M Peters
Aug 15, 2020·Scientific Reports·Maria Cristina MunteanuLin Liu
Nov 15, 2019·Journal of Cellular Biochemistry·Sheng Lu YinGuan Cheng Guo
Jan 31, 2021·Genes·Przemyslaw Szafranski, Paweł Stankiewicz
Dec 29, 2020·Technology in Cancer Research & Treatment·Chuan ChengJianping Wang
Sep 5, 2020·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Tomasz KolendaKatarzyna Lamperska
May 13, 2019·Molecular Immunology·Swati DahariyaRavi Kumar Gutti
Jul 3, 2021·Genes·Maria Cristina MunteanuAshish Ranjan
Jul 1, 2021·Non-coding RNA Research·Ammad Ahmad FarooqiAima Adylova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.